Centers for Medicare and Medicaid Services

AstraZeneca, Rare Disease Research Funding, IRA, Centers for Medicare and Medicaid Services, Inflation Reduction Act, Orphan Drug Act, Lynparza

Legal Skirmishes Erupt as AstraZeneca Delves into Battle Over Drug Pricing Reforms with IRA

Anika Sharma

As the clock ticks down to the eagerly awaited unveiling of the Centers for Medicare and Medicaid Services’ (CMS) list ...

CMS introduces adjustments to Medicare price negotiation while maintaining a strong stance - Pharmtales

CMS introduces adjustments to Medicare price negotiation while maintaining a strong stance

SG Tylor

The Centers for Medicare and Medicaid Services (CMS) has made some minor adjustments to its plan allowing Medicare to negotiate ...

CMS unveils details of its registry strategy for drugs targeting Alzheimer's disease

CMS unveils details of its registry strategy for drugs targeting Alzheimer’s disease

SG Tylor

Centers for Medicare and Medicaid Services (CMS) reveals additional details regarding its controversial plan to mandate participation in a patient ...